Archive - May 2022
NRG receives £2.68m funding boost for neurodegenerative disorders
U.S. Food and Drug Administration Approves Two Opdivo (nivolumab)-Based Regimens as First-Line Treatments for Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma
WHO Dubs Severe Hepatitis In Children ‘Moderate’ Global Health Risk
Confirmed Monkeypox Cases Climb To 257; CDC Raises Travel Alert
CDC Vows To Better Understand Long COVID As Cases Continue To Baffle Experts
Thousands to potentially benefit from Roche treatment for sight loss
AstraZeneca kidney inflammation treatment trial reaches dosing stage
Phase 3 trial initiated to evaluate AZ’s Saphnelo in lupus nephritis